Rightslink® by Copyright Clearance Center

Certolizumab pegol to prevent adverse pregnancy outcomes in patients with antiphospholipid syndrome and lupus anticoagulant (IMPACT): results of a prospective, single-arm, open-label, phase 2 trial

Author:

D. Ware Branch,Mimi Y. Kim,Marta M. Guerra,Joseph Worden,Carl A. Laskin,Maria T. DeSancho,Inna V. Landres,Jason S. Knight,Haley S. Slosberg,Margaret Minett,Jane E. Salmon

Publication:

Annals of Rheumatic Diseases

Publisher:

Elsevier

Date:

June 2025

Please select your organization and/or account

Organization

Account

Please select your account from the above dropdown list. These accounts represent the offices, campuses, and other sites where your organization operates. Your account selection should match where you typically have an office or workspace. Even when you are traveling or temporarily working elsewhere, you should select the account that represents where you customarily work.

Cancel OK

Content Excluded

This content has been excluded from the RightsLink's service. Please contact Elsevier directly with your request.

To request permission for a type of use not listed, please contact Elsevier Global Rights Department.

Are you the author of this Elsevier journal article?